Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjects
Angiotensin-converting enzyme 2 (ACE2) acts as a key receptor for the spike of SARS-CoV-2. Two main microRNAs (miRs), miR-200c-3p and miR-421-5p, are considered to modulate the expression of ACE2 gene and alterations in the expression of these miRNAs may influence the outcomes of COVID-19 infection....
Saved in:
Published in | Infection, genetics and evolution Vol. 98; p. 105207 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.03.2022
The Authors. Published by Elsevier B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Angiotensin-converting enzyme 2 (ACE2) acts as a key receptor for the spike of SARS-CoV-2. Two main microRNAs (miRs), miR-200c-3p and miR-421-5p, are considered to modulate the expression of ACE2 gene and alterations in the expression of these miRNAs may influence the outcomes of COVID-19 infection. Accordingly, we examined whether miRNAs directing ACE2 expression altered in the SARS-CoV-2 infection. 30 patients with COVID-19 included in the study. At the time of admission and discharge, the expression of miR-200c-3p and miR-421-5p, inflammatory cytokine IL-6, and regulatory T cells' expression profiles (CD4, CD25, and Foxp3) were examined using quantitative real-time PCR method. At the time of admission, the expression levels of miR-200c-3p and miR-421-5p as well as CD4, CD25, and Foxp3 significantly decreased while IL-6 expression notably enhanced. However, by the time of discharge, the expression levels of the genes were opposite to the time of admission. Moreover, Pearson correlation analysis indicated that IL-6 expression negatively correlated with Foxp3 and miR-200c-3p expressions despite miR-421-5p and miR-200c-3p positively correlated at admission time. By manipulating miR-200c-3p and miR-421-5p expressions and controlling the ACE2 level, it is plausible to modulate the inflammation by reducing IL-6 and maintenance tolerance hemostasis during COVID-19 infection.
•miRNAs could serve as a novel prognostic marker for SARS-CoV-2 infection.•hsa-miR-200c-3p directly targets ACE2 mRNA leading to decreased ACE2 expression.•miR-421-5p cause a balance between inflammatory and anti-inflammatory processes.•Assessing the levels of miRNA 200c and 451-5p could be important for coronavirus COVID-19 (SARS-CoV-2) patients. |
---|---|
AbstractList | Angiotensin-converting enzyme 2 (ACE2) acts as a key receptor for the spike of SARS-CoV-2. Two main microRNAs (miRs), miR-200c-3p and miR-421-5p, are considered to modulate the expression of ACE2 gene and alterations in the expression of these miRNAs may influence the outcomes of COVID-19 infection. Accordingly, we examined whether miRNAs directing ACE2 expression altered in the SARS-CoV-2 infection. 30 patients with COVID-19 included in the study. At the time of admission and discharge, the expression of miR-200c-3p and miR-421-5p, inflammatory cytokine IL-6, and regulatory T cells' expression profiles (CD4, CD25, and Foxp3) were examined using quantitative real-time PCR method. At the time of admission, the expression levels of miR-200c-3p and miR-421-5p as well as CD4, CD25, and Foxp3 significantly decreased while IL-6 expression notably enhanced. However, by the time of discharge, the expression levels of the genes were opposite to the time of admission. Moreover, Pearson correlation analysis indicated that IL-6 expression negatively correlated with Foxp3 and miR-200c-3p expressions despite miR-421-5p and miR-200c-3p positively correlated at admission time. By manipulating miR-200c-3p and miR-421-5p expressions and controlling the ACE2 level, it is plausible to modulate the inflammation by reducing IL-6 and maintenance tolerance hemostasis during COVID-19 infection.Angiotensin-converting enzyme 2 (ACE2) acts as a key receptor for the spike of SARS-CoV-2. Two main microRNAs (miRs), miR-200c-3p and miR-421-5p, are considered to modulate the expression of ACE2 gene and alterations in the expression of these miRNAs may influence the outcomes of COVID-19 infection. Accordingly, we examined whether miRNAs directing ACE2 expression altered in the SARS-CoV-2 infection. 30 patients with COVID-19 included in the study. At the time of admission and discharge, the expression of miR-200c-3p and miR-421-5p, inflammatory cytokine IL-6, and regulatory T cells' expression profiles (CD4, CD25, and Foxp3) were examined using quantitative real-time PCR method. At the time of admission, the expression levels of miR-200c-3p and miR-421-5p as well as CD4, CD25, and Foxp3 significantly decreased while IL-6 expression notably enhanced. However, by the time of discharge, the expression levels of the genes were opposite to the time of admission. Moreover, Pearson correlation analysis indicated that IL-6 expression negatively correlated with Foxp3 and miR-200c-3p expressions despite miR-421-5p and miR-200c-3p positively correlated at admission time. By manipulating miR-200c-3p and miR-421-5p expressions and controlling the ACE2 level, it is plausible to modulate the inflammation by reducing IL-6 and maintenance tolerance hemostasis during COVID-19 infection. Angiotensin-converting enzyme 2 (ACE2) acts as a key receptor for the spike of SARS-CoV-2. Two main microRNAs (miRs), miR-200c-3p and miR-421-5p, are considered to modulate the expression of ACE2 gene and alterations in the expression of these miRNAs may influence the outcomes of COVID-19 infection. Accordingly, we examined whether miRNAs directing ACE2 expression altered in the SARS-CoV-2 infection. 30 patients with COVID-19 included in the study. At the time of admission and discharge, the expression of miR-200c-3p and miR-421-5p, inflammatory cytokine IL-6, and regulatory T cells' expression profiles (CD4, CD25, and Foxp3) were examined using quantitative real-time PCR method. At the time of admission, the expression levels of miR-200c-3p and miR-421-5p as well as CD4, CD25, and Foxp3 significantly decreased while IL-6 expression notably enhanced. However, by the time of discharge, the expression levels of the genes were opposite to the time of admission. Moreover, Pearson correlation analysis indicated that IL-6 expression negatively correlated with Foxp3 and miR-200c-3p expressions despite miR-421-5p and miR-200c-3p positively correlated at admission time. By manipulating miR-200c-3p and miR-421-5p expressions and controlling the ACE2 level, it is plausible to modulate the inflammation by reducing IL-6 and maintenance tolerance hemostasis during COVID-19 infection. •miRNAs could serve as a novel prognostic marker for SARS-CoV-2 infection.•hsa-miR-200c-3p directly targets ACE2 mRNA leading to decreased ACE2 expression.•miR-421-5p cause a balance between inflammatory and anti-inflammatory processes.•Assessing the levels of miRNA 200c and 451-5p could be important for coronavirus COVID-19 (SARS-CoV-2) patients. Angiotensin-converting enzyme 2 (ACE2) acts as a key receptor for the spike of SARS-CoV-2. Two main microRNAs (miRs), miR-200c-3p and miR-421-5p, are considered to modulate the expression of ACE2 gene and alterations in the expression of these miRNAs may influence the outcomes of COVID-19 infection. Accordingly, we examined whether miRNAs directing ACE2 expression altered in the SARS-CoV-2 infection. 30 patients with COVID-19 included in the study. At the time of admission and discharge, the expression of miR-200c-3p and miR-421-5p, inflammatory cytokine IL-6, and regulatory T cells' expression profiles (CD4, CD25, and Foxp3) were examined using quantitative real-time PCR method. At the time of admission, the expression levels of miR-200c-3p and miR-421-5p as well as CD4, CD25, and Foxp3 significantly decreased while IL-6 expression notably enhanced. However, by the time of discharge, the expression levels of the genes were opposite to the time of admission. Moreover, Pearson correlation analysis indicated that IL-6 expression negatively correlated with Foxp3 and miR-200c-3p expressions despite miR-421-5p and miR-200c-3p positively correlated at admission time. By manipulating miR-200c-3p and miR-421-5p expressions and controlling the ACE2 level, it is plausible to modulate the inflammation by reducing IL-6 and maintenance tolerance hemostasis during COVID-19 infection. |
ArticleNumber | 105207 |
Author | Mohebbi, Seyed Reza Abdolahi, Shahrokh Hosseini, Maryam Mojarad, Ehsan Nazemalhosseini Zali, Mohamad Reza Baghaei, Kaveh Rezaei, Ramazan Asadzadeh Aghdaei, Hamid Mirjalali, Hamed Rostami-Nejad, Mohammad Yadegar, Abbas |
Author_xml | – sequence: 1 givenname: Shahrokh surname: Abdolahi fullname: Abdolahi, Shahrokh organization: Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 2 givenname: Maryam surname: Hosseini fullname: Hosseini, Maryam organization: Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 3 givenname: Ramazan surname: Rezaei fullname: Rezaei, Ramazan organization: Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 4 givenname: Seyed Reza surname: Mohebbi fullname: Mohebbi, Seyed Reza organization: Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 5 givenname: Mohammad surname: Rostami-Nejad fullname: Rostami-Nejad, Mohammad organization: Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 6 givenname: Ehsan Nazemalhosseini surname: Mojarad fullname: Mojarad, Ehsan Nazemalhosseini organization: Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 7 givenname: Hamed surname: Mirjalali fullname: Mirjalali, Hamed organization: Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 8 givenname: Abbas surname: Yadegar fullname: Yadegar, Abbas organization: Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 9 givenname: Hamid surname: Asadzadeh Aghdaei fullname: Asadzadeh Aghdaei, Hamid organization: Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 10 givenname: Mohamad Reza surname: Zali fullname: Zali, Mohamad Reza organization: Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 11 givenname: Kaveh surname: Baghaei fullname: Baghaei, Kaveh email: kavehbaghai@gmail.com organization: Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34999004$$D View this record in MEDLINE/PubMed |
BookMark | eNqNUktv1DAYjFARfcA_QMhHLln8ip1wQEJLgUqVKiHgajn2l61Xib3YTir-Pe7uFgEH4GR_9sxo7Jnz6sQHD1X1nOAVwUS82q4mgI2zK4opLUcNxfJRdUYaIWtJG3ly3BPG29PqPKUtxkRi2j6pThnvug5jflbdXS56nHV2waMwoMl9qinGpmY7pL3dz5ySutmhERYYE7JzdH6D3DTNHlCEtAs-QULOo3wLSNvJ5Qx2z45gwgKxTOubr1fvatKhNPdbMDk9rR4Pekzw7LheVF_eX35ef6yvbz5crd9e14Z3ItekN7xpMB8ktn1rNTAYJOmE6QVwzAbeajMIbrHWDKg1pAWNuaWmPFV0INlF9eagu5v7CawBn6Me1S66ScfvKminfr_x7lZtwqJaybBkogi8PArE8G2GlNXkkoFx1B7CnBQVvG2Z6AT-DyhpS0qMkwJ98autn34egimA1weAiSGlCIMyLu9jKi7dqAhW9y1QW3VogbpvgTq0oJD5H-QH_X_Qjn9VcobFQVTJOPAGrCtJZmWD-7vAD3XIzPo |
CitedBy_id | crossref_primary_10_3390_ijms232415659 crossref_primary_10_1007_s11033_024_09630_2 crossref_primary_10_5812_ijpr_137832 crossref_primary_10_1016_j_jve_2025_100586 crossref_primary_10_3390_life12121964 crossref_primary_10_7759_cureus_57008 crossref_primary_10_1186_s12879_025_10803_y crossref_primary_10_1039_D2SD00140C crossref_primary_10_3390_ijms24043574 crossref_primary_10_3390_ncrna8030029 crossref_primary_10_3390_life12040575 crossref_primary_10_3390_biom13091344 crossref_primary_10_1038_s41392_023_01669_0 crossref_primary_10_3390_ijms26072881 crossref_primary_10_3389_fdmed_2024_1438139 crossref_primary_10_3390_cells11152279 |
Cites_doi | 10.1002/jcp.30047 10.7150/ijms.46695 10.1007/s00134-020-05985-9 10.1172/jci.insight.137799 10.3390/ijms20236008 10.1016/j.cellsig.2014.12.003 10.1111/jvim.15454 10.1038/nature04753 10.1016/j.lfs.2020.118058 10.1172/JCI31202 10.1016/j.cyto.2021.155455 10.1038/nature06306 10.1001/jama.2020.8946 10.1371/journal.pone.0235987 10.1038/nm1267 10.2174/138161207780618867 10.1016/S2213-2600(20)30076-X 10.1002/jcp.28643 10.1016/j.mgene.2020.100831 10.1084/jem.192.2.295 10.1586/1744666X.2014.913482 10.1084/jem.20051166 10.1042/CS20130420 10.1016/j.cytogfr.2020.05.009 10.1016/j.jmii.2020.03.005 10.1073/pnas.0711241105 10.1038/celldisc.2017.21 10.1093/cid/ciaa248 10.1016/j.genrep.2021.101140 10.1016/S0140-6736(20)30183-5 10.1002/path.5471 10.1016/j.ebiom.2020.102763 10.1159/000493805 10.1016/j.cell.2020.02.052 10.1002/eji.201040391 10.1172/JCI137244 10.1128/JVI.01248-09 10.1111/j.1600-0897.2012.01176.x 10.1016/j.yjmcc.2020.08.017 10.1002/jmv.20556 10.1038/s41598-020-76404-8 10.2217/imt.11.79 10.1007/s13277-015-4578-5 10.1016/j.micinf.2009.04.002 10.1056/NEJMoa2002032 10.1002/ppul.23193 |
ContentType | Journal Article |
Copyright | 2022 The Authors Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved. 2022 The Authors 2022 |
Copyright_xml | – notice: 2022 The Authors – notice: Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved. – notice: 2022 The Authors 2022 |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM |
DOI | 10.1016/j.meegid.2022.105207 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE AGRICOLA |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1567-7257 |
EndPage | 105207 |
ExternalDocumentID | PMC8730736 34999004 10_1016_j_meegid_2022_105207 S1567134822000041 |
Genre | Journal Article Comparative Study |
GeographicLocations | Iran |
GeographicLocations_xml | – name: Iran |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 29I 4.4 457 4G. 53G 5GY 5VS 6I. 7-5 71M 8P~ AAAJQ AABVA AACTN AAEDT AAEDW AAFTH AAFWJ AAIAV AAIKJ AAKOC AALCJ AALRI AAOAW AAQFI AAQXK AARKO AATLK AAXUO ABBQC ABFNM ABFRF ABGRD ABGSF ABLVK ABMAC ABMZM ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD ADQTV ADUVX AEBSH AEFWE AEHWI AEKER AENEX AEQOU AFKWA AFPKN AFTJW AFXIZ AGEKW AGHFR AGRDE AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CBWCG CJTIS CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA GROUPED_DOAJ HVGLF HZ~ IHE J1W KOM LCYCR LUGTX M41 MO0 N9A O-L O9- OAUVE OK1 OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SDF SDG SDP SES SEW SPCBC SSA SSH SSI SSU SSZ T5K UHS UNMZH ~G- AAHBH AATTM AAXKI AAYWO AAYXX ABWVN ACIEU ACRPL ACVFH ADCNI ADNMO ADVLN AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 EFKBS L.6 5PM |
ID | FETCH-LOGICAL-c496t-1bc45504f70db8dae3ef7196cb6e403f48acf64d0aa3e2dc18ea04d2c01769e73 |
IEDL.DBID | .~1 |
ISSN | 1567-1348 1567-7257 |
IngestDate | Thu Aug 21 14:12:55 EDT 2025 Tue Aug 05 09:03:17 EDT 2025 Fri Jul 11 02:16:30 EDT 2025 Thu Apr 24 04:15:05 EDT 2025 Tue Jul 01 03:46:26 EDT 2025 Thu Apr 24 23:07:32 EDT 2025 Fri Feb 23 02:39:47 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | COVID-19 miR-200c-3p ACE-2 IL-6 miR-421-5p |
Language | English |
License | This is an open access article under the CC BY license. Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c496t-1bc45504f70db8dae3ef7196cb6e403f48acf64d0aa3e2dc18ea04d2c01769e73 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S1567134822000041 |
PMID | 34999004 |
PQID | 2618520341 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8730736 proquest_miscellaneous_2648836960 proquest_miscellaneous_2618520341 pubmed_primary_34999004 crossref_citationtrail_10_1016_j_meegid_2022_105207 crossref_primary_10_1016_j_meegid_2022_105207 elsevier_sciencedirect_doi_10_1016_j_meegid_2022_105207 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-03-01 |
PublicationDateYYYYMMDD | 2022-03-01 |
PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Infection, genetics and evolution |
PublicationTitleAlternate | Infect Genet Evol |
PublicationYear | 2022 |
Publisher | Elsevier B.V The Authors. Published by Elsevier B.V |
Publisher_xml | – name: Elsevier B.V – name: The Authors. Published by Elsevier B.V |
References | Curiel (bb0065) 2007; 117 Glowacka (bb0075) 2010; 84 Kany, Vollrath, Relja (bb0120) 2019; 20 Joshi (bb0115) 2019; 234 Collison (bb0060) 2007; 450 Iwasaki (bb0110) 2020 Ames, Atkins, Pitt (bb0010) 2019; 33 Hajivalili, Hosseini, Haji-Fatahaliha (bb0095) 2020; 257 Trojanowicz (bb0240) 2019; 141 Haga (bb0090) 2008; 105 Bettelli (bb0030) 2006; 441 Chen (bb0050) 2020; 130 Bergantini (bb0025) 2021; 141 Organization, W.H (bb0190) 2020; 182 Lu (bb0165) 2020; 148 Zhang (bb0275) 2020; 46 Abul Bashar Mir Md Khademul, Khan (bb0005) 2020; 10 Kuba (bb0135) 2005; 11 Read, Malmström, Powrie (bb0215) 2000; 192 Zhou (bb0280) 2016; 37 Wang (bb0250) 2020; 17 Hoffmann (bb0100) 2020; 181 Nersisyan (bb0175) 2020; 15 Lim (bb0150) 2020 Bao (bb0020) 2021; 25 Rossi, Silvestri, Colin (bb0220) 2015; 50 Trojanowicz (bb0235) 2017; 32 Xu (bb0270) 2020; 8 Chen (bb0045) 2011; 3 Li (bb0145) 2007; 13 Kimura, Kishimoto (bb0130) 2010; 40 Kearley (bb0125) 2005; 202 Wu, Yang (bb0260) 2020; 53 Pimenta (bb0205) 2021; 10 Papannarao (bb0195) 2021 Chi (bb0055) 2020 Gubernatorova (bb0085) 2020; 53 Patel, Verma (bb0200) 2020; 323 Liu (bb0155) 2017; 3 Ziegler, Buckner (bb0285) 2009; 11 Guan (bb0080) 2020; 382 Qin (bb0210) 2020; 71 Wang (bb0245) 2015; 27 Liu (bb0160) 2020; 55 Balandya (bb0015) 2012; 68 Głobińska, Pawełczyk, Kowalski (bb0070) 2014; 10 Huang (bb0105) 2020; 395 Soltani-Zangbar (bb0230) 2021; 23 Lambert (bb0140) 2014; 127 Bozgeyik (bb0040) 2021; 27 Wang (bb0255) 2020; 5 Okabayashi (bb0180) 2006; 78 Sadeghi (bb0225) 2020; 236 Onabajo (bb0185) 2020 Mohebbi (bb0170) 2020; 13 Bourgonje (bb0035) 2020; 251 Kany (10.1016/j.meegid.2022.105207_bb0120) 2019; 20 Rossi (10.1016/j.meegid.2022.105207_bb0220) 2015; 50 Sadeghi (10.1016/j.meegid.2022.105207_bb0225) 2020; 236 Lambert (10.1016/j.meegid.2022.105207_bb0140) 2014; 127 Wang (10.1016/j.meegid.2022.105207_bb0245) 2015; 27 Trojanowicz (10.1016/j.meegid.2022.105207_bb0240) 2019; 141 Abul Bashar Mir Md Khademul (10.1016/j.meegid.2022.105207_bb0005) 2020; 10 Huang (10.1016/j.meegid.2022.105207_bb0105) 2020; 395 Nersisyan (10.1016/j.meegid.2022.105207_bb0175) 2020; 15 Okabayashi (10.1016/j.meegid.2022.105207_bb0180) 2006; 78 Bao (10.1016/j.meegid.2022.105207_bb0020) 2021; 25 Bergantini (10.1016/j.meegid.2022.105207_bb0025) 2021; 141 Chi (10.1016/j.meegid.2022.105207_bb0055) 2020 Curiel (10.1016/j.meegid.2022.105207_bb0065) 2007; 117 Zhou (10.1016/j.meegid.2022.105207_bb0280) 2016; 37 Xu (10.1016/j.meegid.2022.105207_bb0270) 2020; 8 Onabajo (10.1016/j.meegid.2022.105207_bb0185) 2020 Hajivalili (10.1016/j.meegid.2022.105207_bb0095) 2020; 257 Haga (10.1016/j.meegid.2022.105207_bb0090) 2008; 105 Liu (10.1016/j.meegid.2022.105207_bb0160) 2020; 55 Bozgeyik (10.1016/j.meegid.2022.105207_bb0040) 2021; 27 Hoffmann (10.1016/j.meegid.2022.105207_bb0100) 2020; 181 Patel (10.1016/j.meegid.2022.105207_bb0200) 2020; 323 Trojanowicz (10.1016/j.meegid.2022.105207_bb0235) 2017; 32 Papannarao (10.1016/j.meegid.2022.105207_bb0195) 2021 Collison (10.1016/j.meegid.2022.105207_bb0060) 2007; 450 Liu (10.1016/j.meegid.2022.105207_bb0155) 2017; 3 Soltani-Zangbar (10.1016/j.meegid.2022.105207_bb0230) 2021; 23 Joshi (10.1016/j.meegid.2022.105207_bb0115) 2019; 234 Read (10.1016/j.meegid.2022.105207_bb0215) 2000; 192 Głobińska (10.1016/j.meegid.2022.105207_bb0070) 2014; 10 Chen (10.1016/j.meegid.2022.105207_bb0050) 2020; 130 Lim (10.1016/j.meegid.2022.105207_bb0150) 2020 Chen (10.1016/j.meegid.2022.105207_bb0045) 2011; 3 Iwasaki (10.1016/j.meegid.2022.105207_bb0110) 2020 Zhang (10.1016/j.meegid.2022.105207_bb0275) 2020; 46 Ames (10.1016/j.meegid.2022.105207_bb0010) 2019; 33 Kuba (10.1016/j.meegid.2022.105207_bb0135) 2005; 11 Bourgonje (10.1016/j.meegid.2022.105207_bb0035) 2020; 251 Gubernatorova (10.1016/j.meegid.2022.105207_bb0085) 2020; 53 Glowacka (10.1016/j.meegid.2022.105207_bb0075) 2010; 84 Organization, W.H (10.1016/j.meegid.2022.105207_bb0190) 2020; 182 Pimenta (10.1016/j.meegid.2022.105207_bb0205) 2021; 10 Kimura (10.1016/j.meegid.2022.105207_bb0130) 2010; 40 Balandya (10.1016/j.meegid.2022.105207_bb0015) 2012; 68 Bettelli (10.1016/j.meegid.2022.105207_bb0030) 2006; 441 Mohebbi (10.1016/j.meegid.2022.105207_bb0170) 2020; 13 Ziegler (10.1016/j.meegid.2022.105207_bb0285) 2009; 11 Li (10.1016/j.meegid.2022.105207_bb0145) 2007; 13 Lu (10.1016/j.meegid.2022.105207_bb0165) 2020; 148 Wang (10.1016/j.meegid.2022.105207_bb0255) 2020; 5 Kearley (10.1016/j.meegid.2022.105207_bb0125) 2005; 202 Wang (10.1016/j.meegid.2022.105207_bb0250) 2020; 17 Qin (10.1016/j.meegid.2022.105207_bb0210) 2020; 71 Wu (10.1016/j.meegid.2022.105207_bb0260) 2020; 53 Guan (10.1016/j.meegid.2022.105207_bb0080) 2020; 382 |
References_xml | – volume: 23 year: 2021 ident: bb0230 article-title: Application of newly developed SARS-CoV2 serology test along with real-time PCR for early detection in health care workers and on-time plasma donation publication-title: Gene Reports – volume: 192 start-page: 295 year: 2000 end-page: 302 ident: bb0215 article-title: Cytotoxic T lymphocyte–associated antigen 4 plays an essential role in the function of CD25+ CD4+ regulatory cells that control intestinal inflammation publication-title: J. Exp. Med. – volume: 141 year: 2021 ident: bb0025 article-title: Prognostic bioindicators in severe COVID-19 patients publication-title: Cytokine – volume: 181 start-page: 271 year: 2020 end-page: 280 ident: bb0100 article-title: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor publication-title: Cell – volume: 234 start-page: 20420 year: 2019 end-page: 20431 ident: bb0115 article-title: Hypoxic regulation of angiotensin-converting enzyme 2 and mas receptor in human CD34+ cells publication-title: J. Cell. Physiol. – start-page: 1 year: 2020 end-page: 22 ident: bb0110 article-title: Inflammation triggered by sars-cov-2 and ace2 augment drives multiple organ failure of severe covid-19: molecular mechanisms and implications publication-title: Inflammation – volume: 10 start-page: 963 year: 2014 end-page: 971 ident: bb0070 article-title: MicroRNAs and the immune response to respiratory virus infections publication-title: Expert. Rev. Clin. Immunol. – volume: 13 start-page: 1257 year: 2007 end-page: 1268 ident: bb0145 article-title: Attenuation of bleomycin-induced pulmonary fibrosis by intratracheal administration of antisense oligonucleotides against angiotensinogen mRNA publication-title: Curr. Pharm. Des. – volume: 20 start-page: 6008 year: 2019 ident: bb0120 article-title: Cytokines in inflammatory disease publication-title: Int. J. Mol. Sci. – volume: 13 start-page: 388 year: 2020 ident: bb0170 article-title: Significant changes of CD4, FOXP3, CD25, and IL6 expression level in Iranian COVID-19 patients publication-title: Gastroenterology and hepatology from bed to bench – volume: 71 start-page: 762 year: 2020 end-page: 768 ident: bb0210 article-title: Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China publication-title: Clinical infectious diseases – volume: 50 start-page: 727 year: 2015 end-page: 732 ident: bb0220 article-title: Respiratory syncytial virus infection of airway cells: role of microRNAs publication-title: Pediatr. Pulmonol. – volume: 382 start-page: 1708 year: 2020 end-page: 1720 ident: bb0080 article-title: Clinical characteristics of coronavirus disease 2019 in China publication-title: N. Engl. J. Med. – volume: 3 start-page: 1 year: 2017 end-page: 17 ident: bb0155 article-title: miRNA-200c-3p is crucial in acute respiratory distress syndrome publication-title: Cell Discovery – volume: 236 start-page: 2829 year: 2020 end-page: 2839 ident: bb0225 article-title: Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls publication-title: J. Cell. Physiol. – volume: 127 start-page: 243 year: 2014 end-page: 249 ident: bb0140 article-title: Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421 publication-title: Clin. Sci. – volume: 8 start-page: 420 year: 2020 end-page: 422 ident: bb0270 article-title: Pathological findings of COVID-19 associated with acute respiratory distress syndrome publication-title: Lancet Respir. Med. – volume: 17 start-page: 1522 year: 2020 ident: bb0250 article-title: A comprehensive investigation of the mRNA and protein level of ACE2, the putative receptor of SARS-CoV-2, in human tissues and blood cells publication-title: Int. J. Med. Sci. – year: 2020 ident: bb0055 article-title: The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) publication-title: Antagonist Tocilizumab man be the Key to Reduce the Mortality – volume: 182 year: 2020 ident: bb0190 article-title: Coronavirus Disease (COVID-19): Situation Report – volume: 148 start-page: 46 year: 2020 end-page: 49 ident: bb0165 article-title: MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes publication-title: J. Mol. Cell. Cardiol. – volume: 68 start-page: 322 year: 2012 end-page: 330 ident: bb0015 article-title: Human seminal plasma fosters CD 4+ regulatory T-cell phenotype and transforming growth factor-β1 expression publication-title: Am J Reprod Immunol – volume: 55 year: 2020 ident: bb0160 article-title: Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients publication-title: EBioMedicine – volume: 202 start-page: 1539 year: 2005 end-page: 1547 ident: bb0125 article-title: Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+ CD25+ regulatory T cells is interleukin 10 dependent publication-title: J Exp Med – volume: 10 start-page: 19395 year: 2020 ident: bb0005 article-title: Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy publication-title: Sci. Rep. – volume: 450 start-page: 566 year: 2007 end-page: 569 ident: bb0060 article-title: The inhibitory cytokine IL-35 contributes to regulatory T-cell function publication-title: Nature – volume: 78 start-page: 417 year: 2006 end-page: 424 ident: bb0180 article-title: Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections publication-title: J. Med. Virol. – volume: 395 start-page: 497 year: 2020 end-page: 506 ident: bb0105 article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China publication-title: The Lancet – volume: 40 start-page: 1830 year: 2010 end-page: 1835 ident: bb0130 article-title: IL-6: regulator of Treg/Th17 balance publication-title: Eur. J. Immunol. – volume: 53 start-page: 13 year: 2020 end-page: 24 ident: bb0085 article-title: IL-6: relevance for immunopathology of SARS-CoV-2 publication-title: Cytokine Growth Factor Rev. – volume: 441 start-page: 235 year: 2006 end-page: 238 ident: bb0030 article-title: Reciprocal developmental pathways for the generation of pathogenic effector TH 17 and regulatory T cells publication-title: Nature – volume: 3 start-page: 911 year: 2011 end-page: 914 ident: bb0045 article-title: Tregs in immunotherapy: opportunities and challenges publication-title: Immunotherapy – volume: 32 start-page: 287 year: 2017 end-page: 298 ident: bb0235 article-title: Monocytic angiotensin-converting enzyme 2 relates to atherosclerosis in patients with chronic kidney disease publication-title: Nephrology Dialysis Transplantation – volume: 5 year: 2020 ident: bb0255 article-title: The laboratory tests and host immunity of COVID-19 patients with different severity of illness publication-title: JCI Insight – volume: 53 start-page: 368 year: 2020 end-page: 370 ident: bb0260 article-title: TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib publication-title: J. Microbiol. Immunol. Infect. – volume: 141 start-page: 61 year: 2019 end-page: 74 ident: bb0240 article-title: Circulating miR-421 targeting leucocytic angiotensin converting enzyme 2 is elevated in patients with chronic kidney disease publication-title: Nephron – volume: 84 start-page: 1198 year: 2010 end-page: 1205 ident: bb0075 article-title: Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63 publication-title: J. Virol. – volume: 37 start-page: 9001 year: 2016 end-page: 9007 ident: bb0280 article-title: miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma publication-title: Tumor Biol. – volume: 27 start-page: 443 year: 2015 end-page: 452 ident: bb0245 article-title: Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia publication-title: Cell. Signal. – volume: 25 start-page: 527 year: 2021 end-page: 540 ident: bb0020 article-title: High expression of ACE2 in the human lung leads to the release of IL6 by suppressing cellular immunity: IL6 plays a key role in COVID-19 publication-title: Eur Rev Med Pharmacol Sci. – volume: 27 year: 2021 ident: bb0040 article-title: Therapeutic potential of miRNAs targeting SARS-CoV-2 host cell receptor ACE2 publication-title: Meta gene – volume: 257 year: 2020 ident: bb0095 article-title: Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges publication-title: Life Sci. – volume: 130 start-page: 2620 year: 2020 end-page: 2629 ident: bb0050 article-title: Clinical and immunological features of severe and moderate coronavirus disease 2019 publication-title: J. Clin. Invest. – volume: 105 start-page: 7809 year: 2008 end-page: 7814 ident: bb0090 article-title: Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry publication-title: Proc. Natl. Acad. Sci. – volume: 323 start-page: 2386 year: 2020 end-page: 2387 ident: bb0200 article-title: Nasal ACE2 levels and COVID-19 in children publication-title: JAMA – volume: 251 start-page: 228 year: 2020 end-page: 248 ident: bb0035 article-title: Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19) publication-title: J. Pathol. – volume: 11 start-page: 875 year: 2005 end-page: 879 ident: bb0135 article-title: A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury publication-title: Nat. Med. – volume: 10 start-page: 141 year: 2021 ident: bb0205 article-title: MiR-200c-3p expression may be associated with worsening of the clinical course of patients with COVID-19 publication-title: Mol Biol Res Commun – volume: 117 start-page: 1167 year: 2007 end-page: 1174 ident: bb0065 article-title: Tregs and rethinking cancer immunotherapy publication-title: J Clin Invest. – volume: 15 year: 2020 ident: bb0175 article-title: Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2 publication-title: PLoS One – start-page: 1 year: 2020 end-page: 11 ident: bb0185 article-title: Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor publication-title: Nat. Genet. – volume: 33 start-page: 363 year: 2019 end-page: 382 ident: bb0010 article-title: The renin-angiotensin-aldosterone system and its suppression publication-title: J. Vet. Intern. Med. – volume: 11 start-page: 594 year: 2009 end-page: 598 ident: bb0285 article-title: FOXP3 and the regulation of Treg/Th17 differentiation publication-title: Microbes Infect. – volume: 46 start-page: 586 year: 2020 end-page: 590 ident: bb0275 article-title: Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target publication-title: Intensive Care Med. – year: 2021 ident: bb0195 article-title: Upregulated miR-200c may increase the risk of obese individuals to severe COVID-19 publication-title: medRxiv – start-page: 1 year: 2020 end-page: 20 ident: bb0150 article-title: COVID-19 and diabetes mellitus: from pathophysiology to clinical management publication-title: Nat. Rev. Endocrinol. – volume: 236 start-page: 2829 issue: 4 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0225 article-title: Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls publication-title: J. Cell. Physiol. doi: 10.1002/jcp.30047 – year: 2021 ident: 10.1016/j.meegid.2022.105207_bb0195 article-title: Upregulated miR-200c may increase the risk of obese individuals to severe COVID-19 publication-title: medRxiv – volume: 17 start-page: 1522 issue: 11 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0250 article-title: A comprehensive investigation of the mRNA and protein level of ACE2, the putative receptor of SARS-CoV-2, in human tissues and blood cells publication-title: Int. J. Med. Sci. doi: 10.7150/ijms.46695 – volume: 46 start-page: 586 issue: 4 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0275 article-title: Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target publication-title: Intensive Care Med. doi: 10.1007/s00134-020-05985-9 – volume: 5 issue: 10 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0255 article-title: The laboratory tests and host immunity of COVID-19 patients with different severity of illness publication-title: JCI Insight doi: 10.1172/jci.insight.137799 – volume: 20 start-page: 6008 issue: 23 year: 2019 ident: 10.1016/j.meegid.2022.105207_bb0120 article-title: Cytokines in inflammatory disease publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms20236008 – volume: 27 start-page: 443 issue: 3 year: 2015 ident: 10.1016/j.meegid.2022.105207_bb0245 article-title: Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia publication-title: Cell. Signal. doi: 10.1016/j.cellsig.2014.12.003 – volume: 33 start-page: 363 issue: 2 year: 2019 ident: 10.1016/j.meegid.2022.105207_bb0010 article-title: The renin-angiotensin-aldosterone system and its suppression publication-title: J. Vet. Intern. Med. doi: 10.1111/jvim.15454 – volume: 441 start-page: 235 issue: 7090 year: 2006 ident: 10.1016/j.meegid.2022.105207_bb0030 article-title: Reciprocal developmental pathways for the generation of pathogenic effector TH 17 and regulatory T cells publication-title: Nature doi: 10.1038/nature04753 – volume: 257 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0095 article-title: Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges publication-title: Life Sci. doi: 10.1016/j.lfs.2020.118058 – volume: 117 start-page: 1167 issue: 5 year: 2007 ident: 10.1016/j.meegid.2022.105207_bb0065 article-title: Tregs and rethinking cancer immunotherapy publication-title: J Clin Invest. doi: 10.1172/JCI31202 – volume: 141 year: 2021 ident: 10.1016/j.meegid.2022.105207_bb0025 article-title: Prognostic bioindicators in severe COVID-19 patients publication-title: Cytokine doi: 10.1016/j.cyto.2021.155455 – volume: 450 start-page: 566 issue: 7169 year: 2007 ident: 10.1016/j.meegid.2022.105207_bb0060 article-title: The inhibitory cytokine IL-35 contributes to regulatory T-cell function publication-title: Nature doi: 10.1038/nature06306 – volume: 323 start-page: 2386 issue: 23 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0200 article-title: Nasal ACE2 levels and COVID-19 in children publication-title: JAMA doi: 10.1001/jama.2020.8946 – volume: 15 issue: 7 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0175 article-title: Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2 publication-title: PLoS One doi: 10.1371/journal.pone.0235987 – volume: 11 start-page: 875 issue: 8 year: 2005 ident: 10.1016/j.meegid.2022.105207_bb0135 article-title: A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury publication-title: Nat. Med. doi: 10.1038/nm1267 – volume: 13 start-page: 1257 issue: 12 year: 2007 ident: 10.1016/j.meegid.2022.105207_bb0145 article-title: Attenuation of bleomycin-induced pulmonary fibrosis by intratracheal administration of antisense oligonucleotides against angiotensinogen mRNA publication-title: Curr. Pharm. Des. doi: 10.2174/138161207780618867 – volume: 8 start-page: 420 issue: 4 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0270 article-title: Pathological findings of COVID-19 associated with acute respiratory distress syndrome publication-title: Lancet Respir. Med. doi: 10.1016/S2213-2600(20)30076-X – volume: 234 start-page: 20420 issue: 11 year: 2019 ident: 10.1016/j.meegid.2022.105207_bb0115 article-title: Hypoxic regulation of angiotensin-converting enzyme 2 and mas receptor in human CD34+ cells publication-title: J. Cell. Physiol. doi: 10.1002/jcp.28643 – volume: 27 year: 2021 ident: 10.1016/j.meegid.2022.105207_bb0040 article-title: Therapeutic potential of miRNAs targeting SARS-CoV-2 host cell receptor ACE2 publication-title: Meta gene doi: 10.1016/j.mgene.2020.100831 – volume: 192 start-page: 295 issue: 2 year: 2000 ident: 10.1016/j.meegid.2022.105207_bb0215 article-title: Cytotoxic T lymphocyte–associated antigen 4 plays an essential role in the function of CD25+ CD4+ regulatory cells that control intestinal inflammation publication-title: J. Exp. Med. doi: 10.1084/jem.192.2.295 – volume: 10 start-page: 963 issue: 7 year: 2014 ident: 10.1016/j.meegid.2022.105207_bb0070 article-title: MicroRNAs and the immune response to respiratory virus infections publication-title: Expert. Rev. Clin. Immunol. doi: 10.1586/1744666X.2014.913482 – volume: 202 start-page: 1539 issue: 11 year: 2005 ident: 10.1016/j.meegid.2022.105207_bb0125 article-title: Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+ CD25+ regulatory T cells is interleukin 10 dependent publication-title: J Exp Med doi: 10.1084/jem.20051166 – volume: 25 start-page: 527 issue: 1 year: 2021 ident: 10.1016/j.meegid.2022.105207_bb0020 article-title: High expression of ACE2 in the human lung leads to the release of IL6 by suppressing cellular immunity: IL6 plays a key role in COVID-19 publication-title: Eur Rev Med Pharmacol Sci. – volume: 127 start-page: 243 issue: 4 year: 2014 ident: 10.1016/j.meegid.2022.105207_bb0140 article-title: Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421 publication-title: Clin. Sci. doi: 10.1042/CS20130420 – year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0055 article-title: The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) – volume: 32 start-page: 287 issue: 2 year: 2017 ident: 10.1016/j.meegid.2022.105207_bb0235 article-title: Monocytic angiotensin-converting enzyme 2 relates to atherosclerosis in patients with chronic kidney disease publication-title: Nephrology Dialysis Transplantation – volume: 53 start-page: 13 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0085 article-title: IL-6: relevance for immunopathology of SARS-CoV-2 publication-title: Cytokine Growth Factor Rev. doi: 10.1016/j.cytogfr.2020.05.009 – volume: 53 start-page: 368 issue: 3 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0260 article-title: TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib publication-title: J. Microbiol. Immunol. Infect. doi: 10.1016/j.jmii.2020.03.005 – volume: 105 start-page: 7809 issue: 22 year: 2008 ident: 10.1016/j.meegid.2022.105207_bb0090 article-title: Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry publication-title: Proc. Natl. Acad. Sci. doi: 10.1073/pnas.0711241105 – volume: 3 start-page: 1 issue: 1 year: 2017 ident: 10.1016/j.meegid.2022.105207_bb0155 article-title: miRNA-200c-3p is crucial in acute respiratory distress syndrome publication-title: Cell Discovery doi: 10.1038/celldisc.2017.21 – start-page: 1 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0110 article-title: Inflammation triggered by sars-cov-2 and ace2 augment drives multiple organ failure of severe covid-19: molecular mechanisms and implications publication-title: Inflammation – volume: 71 start-page: 762 issue: 15 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0210 article-title: Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China publication-title: Clinical infectious diseases doi: 10.1093/cid/ciaa248 – volume: 23 year: 2021 ident: 10.1016/j.meegid.2022.105207_bb0230 article-title: Application of newly developed SARS-CoV2 serology test along with real-time PCR for early detection in health care workers and on-time plasma donation publication-title: Gene Reports doi: 10.1016/j.genrep.2021.101140 – volume: 395 start-page: 497 issue: 10223 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0105 article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China publication-title: The Lancet doi: 10.1016/S0140-6736(20)30183-5 – volume: 251 start-page: 228 issue: 3 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0035 article-title: Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19) publication-title: J. Pathol. doi: 10.1002/path.5471 – volume: 55 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0160 article-title: Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients publication-title: EBioMedicine doi: 10.1016/j.ebiom.2020.102763 – volume: 10 start-page: 141 issue: 3 year: 2021 ident: 10.1016/j.meegid.2022.105207_bb0205 article-title: MiR-200c-3p expression may be associated with worsening of the clinical course of patients with COVID-19 publication-title: Mol Biol Res Commun – volume: 141 start-page: 61 issue: 1 year: 2019 ident: 10.1016/j.meegid.2022.105207_bb0240 article-title: Circulating miR-421 targeting leucocytic angiotensin converting enzyme 2 is elevated in patients with chronic kidney disease publication-title: Nephron doi: 10.1159/000493805 – volume: 181 start-page: 271 issue: 2 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0100 article-title: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor publication-title: Cell doi: 10.1016/j.cell.2020.02.052 – volume: 40 start-page: 1830 issue: 7 year: 2010 ident: 10.1016/j.meegid.2022.105207_bb0130 article-title: IL-6: regulator of Treg/Th17 balance publication-title: Eur. J. Immunol. doi: 10.1002/eji.201040391 – start-page: 1 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0150 article-title: COVID-19 and diabetes mellitus: from pathophysiology to clinical management publication-title: Nat. Rev. Endocrinol. – volume: 130 start-page: 2620 issue: 5 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0050 article-title: Clinical and immunological features of severe and moderate coronavirus disease 2019 publication-title: J. Clin. Invest. doi: 10.1172/JCI137244 – volume: 84 start-page: 1198 issue: 2 year: 2010 ident: 10.1016/j.meegid.2022.105207_bb0075 article-title: Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63 publication-title: J. Virol. doi: 10.1128/JVI.01248-09 – volume: 13 start-page: 388 issue: 4 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0170 article-title: Significant changes of CD4, FOXP3, CD25, and IL6 expression level in Iranian COVID-19 patients publication-title: Gastroenterology and hepatology from bed to bench – volume: 68 start-page: 322 issue: 4 year: 2012 ident: 10.1016/j.meegid.2022.105207_bb0015 article-title: Human seminal plasma fosters CD 4+ regulatory T-cell phenotype and transforming growth factor-β1 expression publication-title: Am J Reprod Immunol doi: 10.1111/j.1600-0897.2012.01176.x – volume: 148 start-page: 46 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0165 article-title: MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2020.08.017 – volume: 78 start-page: 417 issue: 4 year: 2006 ident: 10.1016/j.meegid.2022.105207_bb0180 article-title: Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections publication-title: J. Med. Virol. doi: 10.1002/jmv.20556 – volume: 10 start-page: 19395 issue: 1 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0005 article-title: Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy publication-title: Sci. Rep. doi: 10.1038/s41598-020-76404-8 – volume: 3 start-page: 911 issue: 8 year: 2011 ident: 10.1016/j.meegid.2022.105207_bb0045 article-title: Tregs in immunotherapy: opportunities and challenges publication-title: Immunotherapy doi: 10.2217/imt.11.79 – volume: 182 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0190 – volume: 37 start-page: 9001 issue: 7 year: 2016 ident: 10.1016/j.meegid.2022.105207_bb0280 article-title: miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma publication-title: Tumor Biol. doi: 10.1007/s13277-015-4578-5 – volume: 11 start-page: 594 issue: 5 year: 2009 ident: 10.1016/j.meegid.2022.105207_bb0285 article-title: FOXP3 and the regulation of Treg/Th17 differentiation publication-title: Microbes Infect. doi: 10.1016/j.micinf.2009.04.002 – volume: 382 start-page: 1708 issue: 18 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0080 article-title: Clinical characteristics of coronavirus disease 2019 in China publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2002032 – start-page: 1 year: 2020 ident: 10.1016/j.meegid.2022.105207_bb0185 article-title: Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor publication-title: Nat. Genet. – volume: 50 start-page: 727 issue: 7 year: 2015 ident: 10.1016/j.meegid.2022.105207_bb0220 article-title: Respiratory syncytial virus infection of airway cells: role of microRNAs publication-title: Pediatr. Pulmonol. doi: 10.1002/ppul.23193 |
SSID | ssj0017028 |
Score | 2.402477 |
Snippet | Angiotensin-converting enzyme 2 (ACE2) acts as a key receptor for the spike of SARS-CoV-2. Two main microRNAs (miRs), miR-200c-3p and miR-421-5p, are... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 105207 |
SubjectTerms | ACE-2 Aged Angiotensin-Converting Enzyme 2 - genetics COVID-19 COVID-19 - genetics COVID-19 - immunology COVID-19 infection evolution Female Gene Expression Regulation genes Healthy Volunteers hemostasis Humans IL-6 Immunity - genetics infection inflammation interleukin-6 Iran Male microRNA MicroRNAs - genetics Middle Aged miR-200c-3p miR-421-5p peptidyl-dipeptidase A quantitative polymerase chain reaction SARS-CoV-2 - genetics SARS-CoV-2 - immunology Severe acute respiratory syndrome coronavirus 2 |
Title | Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjects |
URI | https://dx.doi.org/10.1016/j.meegid.2022.105207 https://www.ncbi.nlm.nih.gov/pubmed/34999004 https://www.proquest.com/docview/2618520341 https://www.proquest.com/docview/2648836960 https://pubmed.ncbi.nlm.nih.gov/PMC8730736 |
Volume | 98 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqckFCiDfLY2UkrmaT2Gs7x2pptS2iSEBRb5ZfoUHd7KrZbW_97fXYScRCRSWOTsaS4xnPw5lvBqH3UlpDheGEVtqSoPAkMTIzRFalr6ifWpoDUPjzMZ-fsKPT6ekOmvVYGEir7HR_0ulRW3dPJt1uTlZ1PfkWIg8AQgYLFx3diGBnAqT8w_WQ5pGLLPZXBWIC1D18LuZ4Lbz_WUO90KKAhrcFNJW93Tz97X7-mUX5m1k6eIQedv4k3ktLfox2fPMEPUiXcThhjJ6iq_2hpjdeVnhRfwWxtYSusG5cHLMiJ9MVPoccohYn8CKuATzi8UXKo_UtrhscHEas3aJeB1c1zoaQ-hI6fuLZlx-HH0le4nZj4HqnfYZODva_z-ak67hALCv5muTGAsqZVSJzRjrtqa9EOKPWcM8yWjGpbcWZy7SmvnA2l15nzBU27DMvvaDP0W6zbPxLhP3UUR1MXym5ZZZanTlWWVGK4J9YSfkI0X6jle3KkUNXjHPV5539Uok9CtijEntGiAyzVqkcxx30oueh2hIrFSzGHTPf9SxX4cTBbxTd-OWmVSHmlIEimP9_0QTFCK0SsxF6kcRkWC-FIDMIbFjblgANBFDxe_tNU5_Fyt9SgErmr_77q16j-zBKSXRv0O76YuPfBq9qbcbx2IzRvb3DT_PjcbybuAGbUyJM |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqcgAJIcpzeRqJq9kk9trOsVpabaEtErSoN8tx7BLUza6aXbj1tzMTJ1EXEJU4Jh5Ljmc8D2dmPkLeau0KrgrJeLCOgcLTrNBJwXTIfeB-4niKhcJHx3J2Kj6cTc62yLSvhcG0yk73R53eauvuzbjbzfGyqsZfIPLAQkiwcK2jCyHQLQHHF2EM3l0NeR6pSlqAVaRmSN7Xz7VJXnPvzytsGJpliHibIars3-3Tn_7n72mU1-zS_n1yr3Mo6W5c8w7Z8vUDcjfextFYZPSQ_NwbmnrTRaDz6jPKrWN8SW1dts8iS9lkSS8wiaihsXqRVlg94ullTKT1Da1qCh4jteW8WoGv2s7GmPoHQn7S6aevB-9ZmtNmXeD9TvOInO7vnUxnrINcYE7kcsXSwmGZswgqKQtdWs99UHBIXSG9SHgQ2rogRZlYy31WulR7m4gyc7DPMveKPybb9aL2Twn1k5JbsH25lk447mxSiuBUrsBBcZrLEeH9RhvX9SNHWIwL0yeefTeRPQbZYyJ7RoQNs5axH8cN9KrnodmQKwMm44aZb3qWGzhy-B_F1n6xbgwEnRoowP7_iwY0I2IlJiPyJIrJsF6OUSZILKxtQ4AGAmz5vTlSV9_a1t9aoU6Wz_77q16T27OTo0NzeHD88Tm5gyMxo-4F2V5drv1LcLFWxav2CP0CNMIi5Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+miR-200c-3p+and+miR-421-5p+levels+during+immune+responses+in+the+admitted+and+recovered+COVID-19+subjects&rft.jtitle=Infection%2C+genetics+and+evolution&rft.au=Abdolahi%2C+Shahrokh&rft.au=Hosseini%2C+Maryam&rft.au=Rezaei%2C+Ramazan&rft.au=Mohebbi%2C+Seyed+Reza&rft.date=2022-03-01&rft.issn=1567-7257&rft.eissn=1567-7257&rft.volume=98&rft.spage=105207&rft_id=info:doi/10.1016%2Fj.meegid.2022.105207&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1567-1348&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1567-1348&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1567-1348&client=summon |